---
layout: post
title: "向日葵：拟投资原料药、针剂、口服制剂等集聚提升建设项目"
date: 2022-05-18 21:47:10 +0800
categories: jiemianxinwen
tags: 界面新闻新闻
---
<p style="display:none;height:1px;overflow:hidden;"><br /></p><!-- EM_StockImg_Start --><p style="text-align:center;"><a href="http://quote.eastmoney.com/unify/r/0.300111" data-code="300111|0|2" data-code2="300111|0|80|" class="EmImageRemark" target="_blank"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=0.300111&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" border="0" alt="K图 300111_0" data-code="K 300111|0|2" data-code2="K 300111|0|80|" style="border:#d1d1d1 1px solid;" width="578" height="276" /></a></p><!-- EM_StockImg_End --><p>向日葵5月18日公告，控股子公司贝得药业拟在已竞得地块上投资建设年产原料药500吨、针剂5000万瓶、口服制剂11亿片(粒、袋)集聚提升项目(一期)，预计总投资3.87亿元。<br /></p><p class="em_media">（文章来源：界面新闻）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202205182383864255>

[返回界面新闻新闻](//finews.withounder.com/category/jiemianxinwen.html)｜[返回首页](//finews.withounder.com/)